Events Diary




2nd Annual Chronic Kidney Disease Drug Development Summit

Revere Hotel Boston Common, 200 Stuart Street, Boston 02116, United States

06 May 2019 - 08 May 2019



Summary
2nd CKD3 Summit focuses exclusively on overcoming challenges limiting the development of more efficacious & disease-modifying drugs against diabetic nephropathy, genetic & glomerular kidney disease.

Overview
The 2nd Chronic Kidney Disease Drug Development (CKD3) focuses exclusively on overcoming challenges limiting the development of more efficacious and disease-modifying drugs against diabetic nephropathy, genetic and glomerular kidney disease.

Incorporating insights from 25+ industry leading speakers, this uniquely specific forum assesses key clinical and translational hurdles and the hottest emerging research necessary to achieve the potential of next-generation CKD drugs.

Join 80+ of your colleagues to accelerate the development of SGLT-2 inhibitors, antagonists of renal fibrosis and more, and advance the clinical validity and commercial viability for next-generation standards of care.

More Information »

Want to feature posters from your event on ePosters?


As well as increasing visibility and showcasing the quality of your event, ePosters provides a number of benefits for event organizers.
For information on how ePosters would benefit your event please contact us.